LT - PHARMACEUTICAL COMBINATIONS COMPRISING (A) THE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) INHIBITOR LEE011 (=RIBOCICLIB), AND (B) THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR ERLOTINIB, FOR THE TREATMENT OR PREVENTION OF CANCER
EN - PHARMACEUTICAL COMBINATIONS COMPRISING (A) THE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) INHIBITOR LEE011 (=RIBOCICLIB), AND (B) THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR ERLOTINIB, FOR THE TREATMENT OR PREVENTION OF CANCER
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
| (51) |
INT.CL. |
A61K 31/517 |
|
|
|
A61K 31/519 |
|
|
|
A61P 35/00 |
|
Europos patentas
| (11) |
Patento numeris |
3340990 |
| (13) |
Dokumento rūšis |
T |
| (96) |
Europos patento paraiškos numeris |
16763585.3 |
|
Europos patento paraiškos padavimo data |
2016-08-24 |
| (97) |
Europos patento paraiškos paskelbimo data |
2018-07-04 |
| (45) |
Paskelbimo apie Europos patento išdavimą data |
2019-09-25
|
| (46) |
Apibrėžties vertimo paskelbimo data |
|
Tarptautinės paraiškos padavimo
| (86) |
Numeris |
PCT/IB2016/055044 |
|
Data |
2016-08-24 |
Tarptautinės paraiškos paskelbimo
| (87) |
Numeris |
WO 2017/037576 |
|
Data |
2017-03-09 |
Prioriteto paraiškos
| (30) |
Numeris |
Data |
Šalis |
|
201562211031 P |
2015-08-28
|
US |
Išradėjai
| (72) |
CAPONIGRO, Giordano, US
HORN-SPIROHN, Thomas, US
LEHAR, Joseph, US
|
Savininkas
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Pavadinimas
| (54) |
PHARMACEUTICAL COMBINATIONS COMPRISING (A) THE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) INHIBITOR LEE011 (=RIBOCICLIB), AND (B) THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR ERLOTINIB, FOR THE TREATMENT OR PREVENTION OF CANCER |
| |
PHARMACEUTICAL COMBINATIONS COMPRISING (A) THE CYCLIN DEPENDENT KINASE 4/6 (CDK4/6) INHIBITOR LEE011 (=RIBOCICLIB), AND (B) THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR ERLOTINIB, FOR THE TREATMENT OR PREVENTION OF CANCER |
